K. Lo

发表

Therapeutic Evaluation of Palbociclib and Its Compatibility with Other Chemotherapies in Primary and Recurrent Nasopharyngeal Carcinoma

P. Khong, V. Lee, S. Tsao, 2020 .

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

B. Costello, J. Riess, B. Goh, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frequent hypermethylation of p16 and p15 genes in multiple myeloma.

M. Ng, D. Huang, K. Lo, 1997, Blood.

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.

J. Kwong, P. Johnson, K. To, 2001, Cancer research.

Plasma of Patients with Nasopharyngeal Carcinoma Quantitative Analysis of Cell-free Epstein-Barr Virus DNA in Updated

S. Leung, P. Johnson, N. M. Hjelm, 1999 .

Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma.

S. Leung, Y. Lo, N. M. Hjelm, 1999, Clinical chemistry.

Absence of p53 gene mutations in primary nasopharyngeal carcinomas.

A. Yang, P. Jones, M. Gonzalez-Zulueta, 1992, Cancer research.

High resolution allelotype of microdissected primary nasopharyngeal carcinoma.

K. To, D. Huang, P. Teo, 2000, Cancer research.

Alterations of RAS signalling in Chinese multiple myeloma patients: absent BRAF and rare RAS mutations, but frequent inactivation of RASSF1A by transcriptional silencing or expression of a non‐functional variant transcript

J. Tong, J. Tong, M. Ng, 2003, British journal of haematology.

Regulation of RASSF1A in nasopharyngeal cells and its response to UV irradiation.

C. Man, V. Lee, B. Chow, 2009, Gene.

IKKα-mediated biogenesis of miR-196a through interaction with Drosha regulates the sensitivity of cancer cells to radiotherapy

Y. Tian, J. Jeong, S.-J. Park, 2016, Cell Death and Differentiation.

p53 mutation in human nasopharyngeal carcinomas.

C. Mok, D. Huang, K. Lo, 1992, Anticancer research.